POEM失败后重复经口内窥镜肌切开术治疗贲门失弛缓症的疗效和安全性:一项系统综述和荟萃分析。

IF 2.8 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Umar Hayat, Faisal Kamal, Usman Iqbal Rana, Amna Iqbal, Manesh K Gangwani, Hassam Ali, Keerthy Gopalakrishnan, Umer Farooq, Hafiz M Akbar, Kishore Kumar, Doulas G Adler
{"title":"POEM失败后重复经口内窥镜肌切开术治疗贲门失弛缓症的疗效和安全性:一项系统综述和荟萃分析。","authors":"Umar Hayat, Faisal Kamal, Usman Iqbal Rana, Amna Iqbal, Manesh K Gangwani, Hassam Ali, Keerthy Gopalakrishnan, Umer Farooq, Hafiz M Akbar, Kishore Kumar, Doulas G Adler","doi":"10.1097/MCG.0000000000002117","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Per-oral endoscopic myotomy (POEM) is an effective option for treating achalasia. Despite its high efficacy, a fraction of patients remain symptomatic after POEM, and the data on the optimal management of these patients is limited. Few studies have evaluated the effectiveness of repeat POEM after a failed POEM.</p><p><strong>Aim: </strong>To evaluate the efficacy and safety of repeat POEM for persistent symptoms after the initial POEM.</p><p><strong>Methods: </strong>We searched major databases from inception to April 2024 to identify studies evaluating the efficacy and safety of repeat POEM after failed POEM in patients with achalasia. Our outcomes of interest were clinical success (a reduction in the Eckardt score to ≤3 after the procedure), adverse events, and differences in pre-procedure and post-procedure Eckardt scores. Using the random effects model, we calculated pooled rates with 95% CI for categorical variables and mean difference (MD) with 95% CI for continuous variables.</p><p><strong>Results: </strong>We included 6 observational studies with 123 patients. The mean time between myotomies ranged from 12.2 to 13.5 months. The pooled rate (95% CI) of clinical success was 82.69% (95% CI; 69.65%-93.06%). The pooled rate (95% CI) of adverse events was 17.97% (95% CI: 5.08%-35.15%). The pooled mean±SD post-procedure Eckardt score was 1.63±1.93. The mean post-procedure Eckardt score was significantly lower than the re-procedure Eckardt score, MD (95% CI): 3.68 (2.58, 4.78).</p><p><strong>Conclusion: </strong>Repeated POEM is an effective option for persistent symptoms of achalasia after initial POEM; however, it is associated with nontrivial adverse events.</p>","PeriodicalId":15457,"journal":{"name":"Journal of clinical gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Repeat Per-oral Endoscopic Myotomy After Failed POEM for Achalasia: A Systematic Review and meta-analysis.\",\"authors\":\"Umar Hayat, Faisal Kamal, Usman Iqbal Rana, Amna Iqbal, Manesh K Gangwani, Hassam Ali, Keerthy Gopalakrishnan, Umer Farooq, Hafiz M Akbar, Kishore Kumar, Doulas G Adler\",\"doi\":\"10.1097/MCG.0000000000002117\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Per-oral endoscopic myotomy (POEM) is an effective option for treating achalasia. Despite its high efficacy, a fraction of patients remain symptomatic after POEM, and the data on the optimal management of these patients is limited. Few studies have evaluated the effectiveness of repeat POEM after a failed POEM.</p><p><strong>Aim: </strong>To evaluate the efficacy and safety of repeat POEM for persistent symptoms after the initial POEM.</p><p><strong>Methods: </strong>We searched major databases from inception to April 2024 to identify studies evaluating the efficacy and safety of repeat POEM after failed POEM in patients with achalasia. Our outcomes of interest were clinical success (a reduction in the Eckardt score to ≤3 after the procedure), adverse events, and differences in pre-procedure and post-procedure Eckardt scores. Using the random effects model, we calculated pooled rates with 95% CI for categorical variables and mean difference (MD) with 95% CI for continuous variables.</p><p><strong>Results: </strong>We included 6 observational studies with 123 patients. The mean time between myotomies ranged from 12.2 to 13.5 months. The pooled rate (95% CI) of clinical success was 82.69% (95% CI; 69.65%-93.06%). The pooled rate (95% CI) of adverse events was 17.97% (95% CI: 5.08%-35.15%). The pooled mean±SD post-procedure Eckardt score was 1.63±1.93. The mean post-procedure Eckardt score was significantly lower than the re-procedure Eckardt score, MD (95% CI): 3.68 (2.58, 4.78).</p><p><strong>Conclusion: </strong>Repeated POEM is an effective option for persistent symptoms of achalasia after initial POEM; however, it is associated with nontrivial adverse events.</p>\",\"PeriodicalId\":15457,\"journal\":{\"name\":\"Journal of clinical gastroenterology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-12-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MCG.0000000000002117\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MCG.0000000000002117","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:经口内镜下肌切开术(POEM)是治疗贲门失弛缓症的有效方法。尽管其疗效很高,但一小部分患者在POEM后仍有症状,并且这些患者的最佳管理数据有限。很少有研究评估失败后重复POEM的有效性。目的:评价首次POEM后重复POEM治疗持续性症状的疗效和安全性。方法:我们检索了从成立到2024年4月的主要数据库,以确定评估贲门失弛缓症患者在POEM失败后重复POEM的有效性和安全性的研究。我们感兴趣的结果是临床成功(术后Eckardt评分降至≤3)、不良事件以及术前和术后Eckardt评分的差异。使用随机效应模型,我们计算分类变量的合并率(95% CI)和连续变量的平均差(MD) (95% CI)。结果:我们纳入6项观察性研究,123例患者。两次肌切术的平均间隔时间为12.2至13.5个月。临床成功率(95% CI)为82.69% (95% CI;69.65% - -93.06%)。不良事件合并发生率(95% CI)为17.97% (95% CI: 5.08% ~ 35.15%)。术后Eckardt评分为1.63±1.93。术后Eckardt平均评分显著低于再手术Eckardt评分(95% CI): 3.68(2.58, 4.78)。结论:反复POEM是治疗贲门失弛缓症首次POEM后持续性症状的有效选择;然而,它与重要的不良事件有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy and Safety of Repeat Per-oral Endoscopic Myotomy After Failed POEM for Achalasia: A Systematic Review and meta-analysis.

Background: Per-oral endoscopic myotomy (POEM) is an effective option for treating achalasia. Despite its high efficacy, a fraction of patients remain symptomatic after POEM, and the data on the optimal management of these patients is limited. Few studies have evaluated the effectiveness of repeat POEM after a failed POEM.

Aim: To evaluate the efficacy and safety of repeat POEM for persistent symptoms after the initial POEM.

Methods: We searched major databases from inception to April 2024 to identify studies evaluating the efficacy and safety of repeat POEM after failed POEM in patients with achalasia. Our outcomes of interest were clinical success (a reduction in the Eckardt score to ≤3 after the procedure), adverse events, and differences in pre-procedure and post-procedure Eckardt scores. Using the random effects model, we calculated pooled rates with 95% CI for categorical variables and mean difference (MD) with 95% CI for continuous variables.

Results: We included 6 observational studies with 123 patients. The mean time between myotomies ranged from 12.2 to 13.5 months. The pooled rate (95% CI) of clinical success was 82.69% (95% CI; 69.65%-93.06%). The pooled rate (95% CI) of adverse events was 17.97% (95% CI: 5.08%-35.15%). The pooled mean±SD post-procedure Eckardt score was 1.63±1.93. The mean post-procedure Eckardt score was significantly lower than the re-procedure Eckardt score, MD (95% CI): 3.68 (2.58, 4.78).

Conclusion: Repeated POEM is an effective option for persistent symptoms of achalasia after initial POEM; however, it is associated with nontrivial adverse events.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of clinical gastroenterology
Journal of clinical gastroenterology 医学-胃肠肝病学
CiteScore
5.60
自引率
3.40%
发文量
339
审稿时长
3-8 weeks
期刊介绍: Journal of Clinical Gastroenterology gathers the world''s latest, most relevant clinical studies and reviews, case reports, and technical expertise in a single source. Regular features include cutting-edge, peer-reviewed articles and clinical reviews that put the latest research and development into the context of your practice. Also included are biographies, focused organ reviews, practice management, and therapeutic recommendations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信